Literature DB >> 19806316

Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma.

Pietro Caliandro1, Marco Luigetti, Enzo Ricci, Massimiliano Mirabella, Pietro Attilio Tonali, Luca Padua.   

Abstract

Myasthenia gravis (MG) and paraneoplastic cerebellar degeneration (PCD) are immune-mediated syndromes that can represent paraneoplastic disorders. We report a patient with history of ovarian carcinoma that presented with ptosis, diplopia and gait ataxia. Neurophysiological examination and laboratory tests revealed the presence of MG and PCD. An integrated FDG-PET/contrast-enhanced CT scan showed tumor recurrence. This is to the best of our knowledge the first association of MG and PCD with recurring ovarian carcinoma.

Entities:  

Mesh：

Year:  2009        PMID： 19806316     DOI： 10.1007/s10072-009-0154-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  9 in total

1.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Authors:  W P Mason; F Graus; B Lang; J Honnorat; J Y Delattre; F Valldeoriola; J C Antoine; M K Rosenblum; M R Rosenfeld; J Newsom-Davis; J B Posner; J Dalmau
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

Review 2.  Navigating the paraneoplastic neurological syndromes.

Authors:  Chariklia Giannopoulou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03       Impact factor: 9.236

Review 3.  Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature.

Authors:  V A Lennon
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

Review 4.  Paraneoplastic neurological syndromes: diagnosis and treatment.

Authors:  Francesc Graus; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2007-12       Impact factor: 5.710

5.  P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.

Authors:  F Graus; B Lang; P Pozo-Rosich; A Saiz; R Casamitjana; A Vincent
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

6.  Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.

Authors:  H M Furneaux; M K Rosenblum; J Dalmau; E Wong; P Woodruff; F Graus; J B Posner
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

Review 7.  Paraneoplastic syndromes.

Authors:  J B Posner
Journal:  Neurol Clin       Date:  1991-11       Impact factor: 3.806

8.  Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.

Authors:  Sean J Pittock; Thomas J Kryzer; Vanda A Lennon
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

9.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501
  9 in total
  2 in total

1.  Paraneoplastic Neurological Syndrome in Fallopian Tube Cancer.

Authors:  E Maas; T Skoberne; A Werner; S Braun; C Jackisch
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-10       Impact factor: 2.915

2.  Myasthenia as a paraneoplastic manifestation of ovarian Cancer.

Authors:  Marcelo Simonsen; Marcos Minamoto Miyabe; Helio Toshio Ouki; Antônio Cezar Ribeiro Galvão; Denise Leite; Bárbara Alencar Rolim Murayama; Fabio Martins Laginha; Michelle Samora
Journal:  Gynecol Oncol Rep       Date:  2018-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.